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As America's Waistline Expands, Costs Soar
U.S. hospitals are ripping out wall-mounted toilets and replacing them with floor models to 
better support obese patients. The Federal Transit Administration wants buses to be tested 
for the impact of heavier riders on steering and braking. Cars are burning nearly a billion 
gallons of  gasoline more a year than if passengers weighed what they did in 1960. The 
additional medical spending due to obesity is double previous estimates and exceeds even 
those of smoking, a new study shows.
Higher Sodium Intake Leads to Higher Stroke Risk, New Study Finds
A new study published in the April edition of Stroke found that high sodium intake is 
associated with an increased risk of stroke, independent of vascular risk factors. The study, 
“Dietary Sodium and Risk of Stroke in the Northern Manhattan Study,” assessed four 
ranges of sodium intake among 2,657 participants over 10 years – ≤1,500 mg sodium/day, 
1,501 to 2,300 mg/day, 2,301 to 3,999 mg/day, and ≥4,000 mg/day. Average sodium 
intake was reported as 3,031 mg/day; participants who consumed ≥4,000 mg sodium/day 
had an increased risk of stroke compared to those who consumed ≤1,500 mg/day. The 
study also found that a 500 mg/day increase in sodium intake corresponds to a 17% 
increased risk of stroke. The study may be found here: 
http://stroke.ahajournals.org/content/43/5/1200.full. “Less Salt and Less Risk of Stroke,” a 
related editorial, may be found here: 
http://stroke.ahajournals.org/content/43/5/1195.full. 
New! Interactive Risk Factor Tool
Patient education tool about the most common risk factors for stroke. This easy-to-use
learning tool interactively shows how complicated risk factors, such as atrial fibrillation,
affect the body and increase risk for stroke.  View it now.
New AHA/ASA Guideline on Aneurysmal Subarachnoid Hemorrhage
Lives, Money Saved by Protocol-Guided Transfusion Use
Patients diagnosed with aneurysmal subarachnoid hemorrhage (aSAH) in hospitals that manage fewer than 10 cases per 
year should be considered for immediate transfer to a hospital that treats at least 35 cases a year, according to updated 
guidelines on management of aSAH from the American Heart Association/American Stroke Association (AHA/ASA).
Statewide implementation of a protocol for managing the intraoperative and postoperative use of blood pro-
ducts with cardiac surgery not only cut down on transfusion-related clinical risks, as would have been expected,
it saved money. 
Make the Call. Don't Miss A Beat.
What do you know about heart attack symptoms? Take a short quiz and find out.
What you know could save someone’s life-maybe your own or a loved one’s. 
Learn more today!  Have you seen the Des Moines bus signage?
The Heart Disease and Stroke Prevention Team:
Terry Y. Meek
Program Manager
terry.meek@idph.iowa.gov
Suning Cao 
Epidemiologist
suning.cao@idph.iowa.gov
In any given month, an estimated 48 percent of Americans take at least one prescription drug. 
Prescription drugs are crucial for preventing and treating diseases and improving the public’s health, but
they can also have unintended harmful effects. Often, their benefits and risks cannot be fully identified 
until after a drug has been used by a large, diverse group of patients over time, mainly because clinical 
trials conducted before approval may be too small or too short to detect all possible risks. The IOM 
concludes that the FDA’s current approach to drug oversight in the postmarket setting is not sufficiently
systematic and does not ensure that it assesses the benefits and risks of drugs consistently over the 
drug’s life cycle. Adopting a regulatory framework that is standardized across all drugs, yet flexible enough to adapt to 
regulatory decisions of differing complexity, could help make the agency’s decision-making process more predictable, 
transparent, and proactive. 
Ethical and Scientific Issues in Studying the Safety of Approved Drugs
The poor performance of the United States in life expectancy and other major health outcomes, as 
compared with its global peers reflects what the nation prioritizes in its health investments. It spends 
extravagantly on clinical care but meagerly on other types of population-based actions that influence 
health more profoundly than medical services. The health system’s failure to develop and deliver 
effective preventive strategies continues to take a growing toll on the economy and society. 
In 2009, the IOM formed a committee to consider three topics related to population health: data and 
measurement, law and policy, and funding. In this final report, the IOM assesses both the sources and 
adequacy of current government public health funding and identifies approaches to building a 
sustainable and sufficient public health presence going forward, while recognizing the importance of 
the other actors in the health system, including clinical care, governmental public health, and others. 
For the Public's Health: Investing in a Healthier Future
Primary Care and Public Health: Exploring Integration to Improve Population Health
.
This report calls for primary care physicians and public health professionals to overcome the 
traditional gap separating their respective disciplines as a means of ensuring the health of 
populations. Better collaboration would comprise sharing of data between professionals in the two 
disciplines to improve chronic disease prevention and treatment, 
The report recommends ways that the Centers for Disease Control and Prevention and the Health 
Resources and Services Administration could foster integration between primary care and public 
health through funding, policy levers, and other means.
Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation
Two-thirds of adults and one-third of children are overweight or obese. Left unchecked, obesity’s 
effects on health, health care costs, and our productivity as a nation could become catastrophic. 
The staggering human toll of obesity-related chronic disease and disability, and an annual cost of 
$190.2 billion for treating obesity-related illness, underscore the urgent need to strengthen 
prevention efforts in the United States. The Robert Wood Johnson Foundation asked the IOM to 
identify catalysts that could speed progress in obesity prevention. The IOM evaluated prior obesity 
prevention strategies and identified recommendations to meet five goals and accelerate progress .
